There are critical gaps in biosimilar adoption for pediatric patients, focusing on safety, regulatory challenges, and the ...

The proposed aflibercept biosimilar is intended to treat ophthalmic disorders. This FDA submission follows the licensing agreement under which Fresenius Kabi will exclusively commercialize the ...

Switching to a second TNF inhibitor in inflammatory bowel disease may raise the risk for immune-mediated inflammatory ...

When a patient leaves a review, it’s easy to think of it as digital noise — a single rating among many. But a new national report from Tebra, a medical practice management system company based in ...

Amneal wins FDA approval for two denosumab biosimilars, expanding lower-cost treatment options for bone loss and cancer patients.

A patient of San Diego-based Sharp HealthCare is suing the health system over its use of an AI scribe during his treatment. The plaintiff claims a Sharp Rees-Stealy Medical Group clinic recorded a ...

A research team led by the Medical University of Vienna and the University of Vienna has investigated a possible link between ...

A recent randomised controlled trial showed that proton pump inhibitors (PPIs), compared with histamine-2 receptor antagonists (H2RAs), induce greater gut microbiome alterations and oral-to-gut ...

With 9.5% of its population estimated to be HIV-positive in 2019, Malawi has one of the highest rates of HIV prevalence in the world. While untreated HIV can lead to infection and death, ...

A team led by scientists at King's College London, in collaboration with national and international partners, has discovered how a specific group of immune cells in the gut—Group 3 Innate Lymphoid ...

For people living with chronic inflammatory diseases, the immune system can feel like a switch that is stuck in the ‘on’ ...

On May 16, as cameras flashed and tribal leaders looked on, Arizona’s governor and attorney general announced a statewide crackdown on behavioral health providers suspected of defrauding the state’s ...